L166P mutant DJ-1, causative for recessive Parkinson's disease, is degraded through the ubiquitin-proteasome system

David W Miller1, Rili Ahmad, Stephen Hague

  • 1Laboratory of Neurogenetics, NIA, National Institutes of Health, Bethesda, Maryland 20892-1589, USA.

Insights

The L166P mutation destabilizes DJ-1 protein, leading to its degradation and reduced levels in cells. This finding clarifies the impact of DJ-1 mutations in early-onset Parkinson's disease.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Mutations in the DJ-1 gene on chromosome 1 are linked to recessive, early-onset Parkinson's disease.
  • A large deletion causes DJ-1 knockout, but the functional impact of the L166P point mutation remains unclear.

Purpose of the Study:

  • To investigate the precise effects of the L166P mutation on DJ-1 protein function and stability.
  • To elucidate the mechanism by which the L166P mutation contributes to Parkinson's disease pathogenesis.

Main Methods:

  • Protein stability assays were performed on wild-type and mutant DJ-1 proteins.
  • Ubiquitin-proteasome system involvement was assessed.
  • Subcellular localization studies were conducted for wild-type and L166P DJ-1.

Main Results:

  • The L166P mutation significantly destabilizes DJ-1 protein, promoting its degradation via the ubiquitin-proteasome system.
  • A double mutant (K130R, L166P) exhibited increased stability compared to L166P, indicating a role for lysine at position 130 in protein stability.
  • Subcellular localization of L166P DJ-1 was similar to wild-type, suggesting the primary effect is on protein stability rather than cellular distribution.

Conclusions:

  • The L166P mutation primarily affects DJ-1 protein stability, leading to increased degradation and reduced cellular DJ-1 levels.
  • This loss-of-function mechanism is consistent with other recessive DJ-1 mutations associated with Parkinson's disease.
  • Understanding the impact of L166P on DJ-1 stability provides insights into the molecular basis of early-onset Parkinson's disease.

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...